Publications by authors named "Lisa Holthof"

Claim this Profile
B
Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis.
Lisa C Holthof, Jort J van der Schans, Afroditi Katsarou, Renée Poels, Anne T Gelderloos

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant.
Lisa C Holthof, Arwen Stikvoort, Hilma J van der Horst, Anne T Gelderloos, Renée Poels

Hemasphere· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma.
Lisa C Holthof, Hilma J van der Horst, Susan E van Hal-van Veen, Ruud W J Ruiter, Fengzhi Li

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab.
Kristine A Frerichs, Marloes E C Broekmans, Jhon A Marin Soto, Berris van Kessel, Martijn W Heymans, Lisa C Holthof

Clin Cancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges for Immunotherapy in Multiple Myeloma: Bone Marrow Microenvironment-Mediated Immune Suppression and Immune Resistance.
Lisa C Holthof, Tuna Mutis

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.
Morten Nørgaard Andersen, Anders Etzerodt, Jonas H Graversen, Lisa C Holthof, Søren K Moestrup

Cancer Immunol Immunother· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.
Sanne J de Haart, Lisa Holthof, Willy A Noort, Monique C Minnema, Maarten E Emmelot

Haematologica· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis